PubMed

Fulminant hepatic failure associated with 2',3'-dideoxyinosine (ddI).

Lai KK, Gang DL, Zawacki JK, Cooley TP.

Ann Intern Med. 1991 Aug 15;115(4):283-4. No abstract available. PMID: 1906693 [PubMed - indexed for MEDLINE]Related articles

Fatal case of 2',3'-dideoxyinosine-associated pancreatitis.

Bouvet E, Casalino E, Prevost MH, Vachon F.

Lancet. 1990 Dec 15;336(8729):1515. No abstract available. PMID: 1979129 [PubMed - indexed for MEDLINE]Related articles

Hepatic toxicity associated with 2'-3' dideoxyinosine in children with AIDS.

Lacaille F, Ortigao MB, Debré M, Rouzioux C, Brousse N, Blanche S.

J Pediatr Gastroenterol Nutr. 1995 Apr;20(3):287-90.PMID: 7608823 [PubMed - indexed for MEDLINE]Related articles

Acute pancreatitis as a common complication of 2',3'-dideoxyinosine therapy in the acquired immunodeficiency syndrome.

Maxson CJ, Greenfield SM, Turner JL.

Am J Gastroenterol. 1992 Jun;87(6):708-13.PMID: 1590305 [PubMed - indexed for MEDLINE]Related articles

2',3'-dideoxyinosine (ddI) in patients with the acquired immunodeficiency syndrome or AIDS-related complex. A phase I trial.

Lambert JS, Seidlin M, Reichman RC, Plank CS, Laverty M, Morse GD, Knupp C, McLaren C, Pettinelli C, Valentine FT, et al.

N Engl J Med. 1990 May 10;322(19):1333-40.PMID: 2139173 [PubMed - indexed for MEDLINE]Related articles

Dideoxyinosine-induced pancreatitis in human immunodeficiency virus-infected children.

Levin TL, Berdon WE, Tang HB, Haller JO.

Pediatr Radiol. 1997 Feb;27(2):189-91.PMID: 9028860 [PubMed - indexed for MEDLINE]Related articles

Phase I study of 2',3'-dideoxyinosine: experience with 19 patients at New York University Medical Center.

Valentine FT, Seidlin M, Hochster H, Laverty M.

Rev Infect Dis. 1990 Jul-Aug;12 Suppl 5:S534-9.PMID: 1974725 [PubMed - indexed for MEDLINE]Related articles

Pancreatitis and pancreatic dysfunction in patients taking dideoxyinosine.

Seidlin M, Lambert JS, Dolin R, Valentine FT.

AIDS. 1992 Aug;6(8):831-5.PMID: 1418780 [PubMed - indexed for MEDLINE]Related articles

The National Cancer Institute phase I study of 2',3'-dideoxyinosine administration in adults with AIDS or AIDS-related complex: analysis of activity and toxicity profiles.

Yarchoan R, Mitsuya H, Pluda JM, Marczyk KS, Thomas RV, Hartman NR, Brouwers P, Perno CF, Allain JP, Johns DG, et al.

Rev Infect Dis. 1990 Jul-Aug;12 Suppl 5:S522-33.PMID: 1974724 [PubMed - indexed for MEDLINE]Related articles

Overview of phase I trials of 2',3'-dideoxyinosine (ddI) conducted on adult patients.

Rozencweig M, McLaren C, Beltangady M, Ritter J, Canetta R, Schacter L, Kelley S, Nicaise C, Smaldone L, Dunkle L, et al.

Rev Infect Dis. 1990 Jul-Aug;12 Suppl 5:S570-5.PMID: 2166965 [PubMed - indexed for MEDLINE]Related articles

Fulminant hepatitis with severe lactate acidosis in HIV-infected patients on didanosine therapy.

Bissuel F, Bruneel F, Habersetzer F, Chassard D, Cotte L, Chevallier M, Bernuau J, Lucet JC, Trepo C.

J Intern Med. 1994 Apr;235(4):367-71.PMID: 8151270 [PubMed - indexed for MEDLINE]Related articles

Treatment of AIDS and AIDS-related complex with 2',3'-dideoxyinosine given once daily.

Cooley TP, Kunches LM, Saunders CA, Perkins CJ, Kelley SL, McLaren C, McCaffrey RP, Liebman HA.

Rev Infect Dis. 1990 Jul-Aug;12 Suppl 5:S552-60.PMID: 1974727 [PubMed - indexed for MEDLINE]Related articles

Once-daily administration of 2',3'-dideoxyinosine (ddI) in patients with the acquired immunodeficiency syndrome or AIDS-related complex. Results of a Phase I trial.

Cooley TP, Kunches LM, Saunders CA, Ritter JK, Perkins CJ, McLaren C, McCaffrey RP, Liebman HA.

N Engl J Med. 1990 May 10;322(19):1340-5.PMID: 2139174 [PubMed - indexed for MEDLINE]Related articles

Pancreatitis in AIDS patients treated with didanosine.

Daniels M.

Am J Gastroenterol. 1993 Mar;88(3):459-60. No abstract available. PMID: 8438864 [PubMed - indexed for MEDLINE]Related articles

A dose comparison study of didanosine in patients with very advanced HIV infection who are intolerant to or clinically deteriorate on zidovudine. German ddI Trial Group.

Jablonowski H, Arasteh K, Staszewski S, Ruf B, Stellbrink HJ, Schrappe M, Stoehr A, Haase W, Schomaker U, von Eisenhart Rothe B, et al.

AIDS. 1995 May;9(5):463-9.PMID: 7639971 [PubMed - indexed for MEDLINE]Related articles

NIAID updates dideoxyinosine toxicity profile, suggests ways to reduce risk of pancreatitis.

[No authors listed]

Clin Pharm. 1990 Nov;9(11):832, 838. No abstract available. PMID: 2125539 [PubMed - indexed for MEDLINE]Related articles

Analysis of potential risk factors associated with the development of pancreatitis in phase I patients with AIDS or AIDS-related complex receiving didanosine.

Grasela TH, Walawander CA, Beltangady M, Knupp CA, Martin RR, Dunkle LM, Barbhaiya RH, Pittman KA, Dolin R, Valentine FT, et al.

J Infect Dis. 1994 Jun;169(6):1250-5.PMID: 8195601 [PubMed - indexed for MEDLINE]Related articles

New drug therapy for patients with HIV. Nursing implications in the administration of 2',3'-dideoxyinosine (ddI).

Shay LE, Thomas RV, Wyvill KM, Adamo DO, Jenkins JF.

Cancer Nurs. 1990 Oct;13(5):269-77.PMID: 2123127 [PubMed - indexed for MEDLINE]Related articles

The impact of ethanol and Marinol/marijuana usage on HIV+/AIDS patients undergoing azidothymidine, azidothymidine/dideoxycytidine, or dideoxyinosine therapy.

Whitfield RM, Bechtel LM, Starich GH.

Alcohol Clin Exp Res. 1997 Feb;21(1):122-7.PMID: 9046384 [PubMed - indexed for MEDLINE]Related articles

2',3'-Dideoxyinosine in patients with AIDS or AIDS-related complex.

Dolin R, Lambert JS, Morse GD, Reichman RC, Plank CS, Reid J, Knupp C, McLaren C, Pettinelli C.

Rev Infect Dis. 1990 Jul-Aug;12 Suppl 5:S540-9; discussion S549-51.PMID: 1974726 [PubMed - indexed for MEDLINE]Related articles